Evidence map›Paper›PMID 39242621›Full record

ArticleScientific reports2024

mTORC1 pathway activity biases cell fate choice.

Yuntao Wang, Monika Papayova, Eleanor Warren, Catherine J Pears

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuntao WangDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
Monika PapayovaDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
Eleanor WarrenDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
Catherine J PearsDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK. catherine.pears@bioch.ox.ac.uk.

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/M000834/1
6 · The paper itself

Abstract

Pluripotent stem cells can differentiate into distinct cell types but the intracellular pathways controlling cell fate choice are not well understood. The social amoeba Dictyostelium discoideum is a simplified system to study choice preference as proliferating amoebae enter a developmental cycle upon starvation and differentiate into two major cell types, stalk and spores, organised in a multicellular fruiting body. Factors such as acidic vesicle pH predispose amoebae to one fate. Here we show that the mechanistic target of rapamycin complex 1 (mTORC1) pathway has a role in cell fate bias in Dictyostelium. Inhibiting the mTORC1 pathway activity by disruption of Rheb (activator Ras homolog enriched in brain), or treatment with the mTORC1 inhibitor rapamycin prior to development, biases cells to a spore cell fate. Conversely activation of the pathway favours stalk cell differentiation. The Set1 histone methyltransferase, responsible for histone H3 lysine4 methylation, in Dictyostelium cells regulates transcription at the onset of development. Disruption of Set1 leads to high mTORC1 pathway activity and stalk cell predisposition. The ability of the mTORC1 pathway to regulate cell fate bias of cells undergoing differentiation offers a potential target to increase the efficiency of stem cell differentiation into a particular cell type.

Indexed as

Cell DifferentiationDictyosteliumMechanistic Target of Rapamycin Complex 1Signal TransductionHistone-Lysine N-MethyltransferaseMonomeric GTP-Binding ProteinsProtozoan ProteinsSirolimusHistone-Lysine N-MethyltransferaseMechanistic Target of Rapamycin Complex 1Monomeric GTP-Binding ProteinsProtozoan ProteinsSirolimusCell fate choiceDictyostelium discoideummTORC1RapamycinSet1

Identifiers

PMID39242621
PMCPMC11379915

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.